Chimeric Antigen Receptor T-Cell (CAR T-cell) therapy represents a groundbreaking advancement in cancer treatment, harnessing the power of the body's own immune system to target and destroy cancer cells. This innovative therapy involves modifying a patient’s T-cells to express a receptor specific to cancer antigens. The CAR T-cell therapy market has witnessed significant growth, driven by...
English
Arabic
Français
Español
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian